CIGEX
Price
$21.96
Change
+$0.09 (+0.41%)
Updated
Jun 22 closing price
Net Assets
204.55M
RNPEX
Price
$73.61
Change
-$0.11 (-0.15%)
Updated
Jun 22 closing price
Net Assets
171.51B
Interact to see
Advertisement

CIGEX vs RNPEX

CIGEX vs RNPEX Comparison Chart in %
View a ticker or compare two or three
VS
CIGEX vs. RNPEX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIGEX is a Buy and RNPEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 172B vs. CIGEX (205M). RNPEX pays higher dividends than CIGEX: RNPEX (0.93) vs CIGEX (0.00). CIGEX was incepted earlier than RNPEX: CIGEX (19 years) vs RNPEX (24 years). CIGEX (1.25) is less costly to investors than RNPEX (0.75). CIGEX is a more actively managed with annual turnover of: 114.00 vs. RNPEX (23.00). RNPEX has a lower initial minimum investment than CIGEX: RNPEX (250) vs CIGEX (1000000). CIGEX annual gain was more profitable for investors over the last year : 17.83 vs. RNPEX (13.27). CIGEX return over 5 years is better than : 23.12 vs. RNPEX (15.70).
CIGEXRNPEXCIGEX / RNPEX
Total Expense Ratio1.150.75153%
Annual Report Gross Expense Ratio1.250.75167%
Fund Existence19 years24 years-
Gain YTD21.6356.434336%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets205M172B0%
Annual Yield % from dividends0.000.93-
Returns for 1 year17.8313.27134%
Returns for 3 years64.1041.47155%
Returns for 5 years23.1215.70147%
Returns for 10 years82.77122.9267%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETHT9.140.28
+3.16%
Proshares Ultra Ether ETF
SEMI40.720.14
+0.34%
Columbia Select Technology ETF
IMRA17.23N/A
N/A
Bitwise MARA Option Income Strategy ETF
JSI51.27-0.07
-0.14%
Janus Henderson Securitized Income ETF
BTAL10.92-0.04
-0.36%
AGF U.S. Market Neutral Anti-Beta